A detailed history of Bellevue Group Ag transactions in Si Bone, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 1,444,109 shares of SIBN stock, worth $18.1 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,444,109
Previous 1,387,609 4.07%
Holding current value
$18.1 Million
Previous $17.9 Million 12.52%
% of portfolio
0.34%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$12.9 - $17.11 $728,850 - $966,715
56,500 Added 4.07%
1,444,109 $20.2 Million
Q2 2024

Aug 14, 2024

BUY
$11.93 - $16.34 $2.95 Million - $4.05 Million
247,653 Added 21.72%
1,387,609 $17.9 Million
Q1 2024

May 15, 2024

BUY
$15.15 - $21.58 $15.4 Million - $21.9 Million
1,014,756 Added 810.51%
1,139,956 $18.7 Million
Q4 2023

Feb 14, 2024

BUY
$15.75 - $21.38 $1.97 Million - $2.68 Million
125,200 New
125,200 $2.63 Million

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $431M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.